Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-378-9 | CAS number: 5384-21-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from study report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Principles of method if other than guideline:
- The aim of this study was to assess the toxicity potential of test chemical after single oral administration in rats.
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 4,4'-methylenedi-2,6-xylenol
- EC Number:
- 226-378-9
- EC Name:
- 4,4'-methylenedi-2,6-xylenol
- Cas Number:
- 5384-21-4
- Molecular formula:
- C17H20O2
- IUPAC Name:
- 4-[(4-hydroxy-3,5-dimethylphenyl)methyl]-2,6-dimethylphenol
- Test material form:
- solid
- Details on test material:
- - Name of test material (as cited in study report):4,4'-methylenedi-2,6-xylenol
- Molecular formula :C17H20O2
- Molecular weight :256.34 g/mol
- Substance type:Organic
- Physical state:White Solid (Powder)
- Analytical purity:99.79%
- Lot/batch No.:Lot 1/03
- Storage condition of test material:Stored in cool, dry place. Kept container closed when not in use.
- Other:
Handling and Disposal
Safety precautions: Avoided excessive heat and light. Did not breath dust. Aprons, caps, gloves and goggles were used to ensure the health and safety of the Personnel.
Disposal:The remaining unused test item formulations were disposed as per internal SOPs of sa-FORD.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Bharat Serum and Vaccines Limited.
- Age at study initiation:8- 11 weeks at the time of dosing.
- Health Status :Healthy young adult animals were used for the study. Females were nulliparous and non pregnant.
- Weight at study initiation:Minimum: 183 g and Maximum: 216 g (Individual body weights were within ± 5% prior to treatment after overnight fasting).
- Fasting period:The animals were fasted for minimum 16-18 hours prior to dosing and for 3-4 hours post dosing.
- Housing:The animals were housed individually in polycarbonate cages.
- Bedding:All cages were provided with corn cobs.
- Room Sanitation:The experimental room floor and work tops were swept and mopped with disinfectant solution every day.
- Cages and water bottle:All the cages and water bottles were changed at least twice every week.
- Diet (e.g. ad libitum):All animals were provided conventional laboratory rodent diet (Nutrivet Life Sciences, Pune) ad libitum.
- Water (e.g. ad libitum):Aqua guard filtered tap water was provided ad libitum via drinking bottles.
- Acclimation period:Animal nos. 1-3 were acclimatized for five days, 4-6 for seven days, 7-9 for nine days and 10-12 for six days prior to administration of the test item.
ENVIRONMENTAL CONDITIONS
- Temperature (°C):Minimum: 20.00 °C and Maximum: 23.60 °C.
- Humidity (%):Minimum: 37.40% and Maximum: 61.80%
- Air changes (per hr):More than 12 changes per hour.
- Photoperiod (hrs dark / hrs light):12:12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle:10 ml
- Justification for choice of vehicle:Corn oil was selected because test item was not soluble in distilled water.
- Lot/batch no. (if required):MKBD4650
- Purity:N/A
MAXIMUM DOSE VOLUME APPLIED:10 ml/kg body weight. - Doses:
- G1 = 300 mg/kg bw
G2 = 2000 mg/kg bw - No. of animals per sex per dose:
- Twelve female rats
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:Daily
- Necropsy of survivors performed: yes
At the end of 14 day observation period, all the survived rats were euthanised by overdose of CO2 for external and internal observations.
- Other examinations performed:
Clinical Observation - After test item administration, individual animals were frequently observed at 30 minutes, 1, 2, 3 and 4 hours post dosing on day 0 (day of dosing). Additionally, on day 0 animal nos. 7-9 were observed at 6 hours post dosing. Subsequently, all the animals were observed once a day during the 14 day observation period.
Body weight - All rats were weighed on days 0 (prior to dosing), 7 and 14. Animals were weighed immediately after found dead.
other: Mortality - All the animals were observed twice daily (morning and evening) for morbidity and mortality, throughout the acclimatization and study period. - Statistics:
- No data
Results and discussion
- Preliminary study:
- No data
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Non toxic to rat.
- Mortality:
- No mortality was observed in the animals treated with 300 and 2000 mg/kg dose throught out the 14 days observation period post dosing.
- Clinical signs:
- other: At 300 mg/kg, all the six animals (animal nos. 1-6) were observed normal throughout experimental period. At 2000mg/kg, animal no. 7 was observed normal at 30 minutes and 1 hour post dosing, mild to moderate lethargy at 2, 3, 4 and 6 hours and mild ataxia
- Gross pathology:
- No external and internal gross pathological changes were seen in all the six animals treated with 300 and 2000 mg/kg body weight during terminal sacrifice
- Other findings:
- No data
Any other information on results incl. tables
Table 1: Individual Animal Body Weight (g) andBody Weight Changes(%)
Sex:Female
Animal No. |
Group/ Dose (mg/kg) |
Body Weight (gram) |
Body Weight Change (%) |
|||
Day 0 |
Day 7 |
Day 14 |
Day 0-7 |
Day 0-14 |
||
1 |
G1/ 300 |
210 |
223 |
234 |
6.19 |
11.43 |
2 |
204 |
229 |
234 |
12.25 |
14.71 |
|
3 |
200 |
230 |
237 |
15.00 |
18.50 |
|
4 |
216 |
240 |
253 |
11.11 |
17.13 |
|
5 |
204 |
240 |
246 |
17.65 |
20.59 |
|
6 |
198 |
237 |
218 |
19.70 |
10.10 |
|
7 |
G2/ 2000 |
210 |
219 |
229 |
4.29 |
9.05 |
8 |
197 |
228 |
224 |
15.74 |
13.71 |
|
9 |
195 |
220 |
235 |
12.82 |
20.51 |
|
10 |
187 |
217 |
229 |
16.04 |
22.46 |
|
11 |
183 |
219 |
228 |
19.67 |
24.59 |
|
12 |
185 |
215 |
229 |
16.22 |
23.78 |
Table 2: Summary of Animal Body Weight (g) and Body Weight Changes (%)
Sex:Female
Group/ Dose (mg/kg) |
Rats Body Weight (g) |
Body Weight Changes (%) |
||||
Day 0 |
Day 7 |
Day 14 |
0-7 |
0-14 |
||
G1/ 300 |
Mean |
205.33 |
233.17 |
237.00 |
13.65 |
15.41 |
SD |
6.65 |
6.91 |
11.97 |
4.87 |
4.10 |
|
n |
6 |
6 |
6 |
6 |
6 |
|
G2/ 2000 |
Mean |
192.83 |
219.67 |
229.00 |
14.13 |
19.02 |
SD |
10.09 |
4.46 |
3.52 |
5.29 |
6.25 |
|
n |
6 |
6 |
6 |
6 |
6 |
Keys:SD = Standard Deviation, n = Number of Animals
Table 3: Individual Animal Clinical Signs and Symptoms
Sex:Female
Animal No. |
Group/ Dose (mg/kg) |
Hours (Day 0) |
|||||
1/2 |
1 |
2 |
3 |
4 |
6 |
||
1 |
G1/ 300 |
1 |
1 |
1 |
1 |
1 |
- |
2 |
1 |
1 |
1 |
1 |
1 |
- |
|
3 |
1 |
1 |
1 |
1 |
1 |
- |
|
4 |
1 |
1 |
1 |
1 |
1 |
- |
|
5 |
1 |
1 |
1 |
1 |
1 |
- |
|
6 |
1 |
1 |
1 |
1 |
1 |
- |
|
7 |
G2/ 2000 |
1 |
1 |
99+ |
99++ 21+ |
99++ 21+ |
99++ 21+ |
8 |
1 |
1 |
99+ |
99++ 21+ |
99+++ 21+ |
99+++ 21++ |
|
9 |
1 |
1 |
99++ 21+ |
99+++ 21++ |
99+++ 21++ |
99+++ 21++ |
|
10 |
1 |
1 |
99+ |
99++ 21+ |
99++ 21+ |
- |
|
11 |
1 |
1 |
99+ |
99++ 21+ |
99++ 21+ |
- |
|
12 |
1 |
1 |
99+ |
99++ 21+ |
99++ 21++ |
- |
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified
- Conclusions:
- Under the conditions of this; acute oral toxicity study of test chemical in female rats is as given below:
The acute oral LD50 value of test chemical was considered to be >2000 mg/kg body weight. Thus by considering the CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not exhibit acute oral toxicity i.e it is acutely non toxic to animals. - Executive summary:
Acute Oral Toxicity Study was conducted by using the given test chemical in Rats, This study was performed as per OECD No. 423.
Twelve female Wistar rats were selected for acute oral toxicity study. The animals were fasted for minimum 16-18 hours prior to dosing and for 3-4 hours post dosing, with food withheld but drinking water provided ad libitum. The time intervals between dosing were determined by the onset, duration and severity of toxic signs. Three rats of group G1 were dosed with starting dose of 300 mg/kg body weight and the animals did not show any mortality so another three animals of the group G1 were dosed with 300 mg/kg body weight and no mortality was observed. Three animals of the group G2 were dosed with 2000 mg/kg body weight and no mortality was observed, therefore another three animals of same group G2 were dose with 2000 mg/kg and no mortality was observed. Hence, further dosing was stopped. Body weights were re¬corded on day 0 (prior to dosing) 7 and 14. Mean body weight was observed with gain was observed in the animals treated with 300 and 2000 mg/kg body weight, during the 14 day observation period, as compared to day 0. At 300 mg/kg, all the six animals (animal nos. 1-6) were observed normal throughout experimental period. At 2000 mg/kg, animal no. 7 was observed normal at 30 minutes and 1 hour post dosing, mild to moderate lethargy at 2, 3, 4 and 6 hours and mild ataxia at 3, 4 and 6 hours followed by normal clinical sign till day 14. Animal no. 8 was observed normal at 30 minutes and 1 hour post dosing, mild to severe lethargy at 2, 3, 4 and 6 hours and mild to moderate ataxia at 3, 4 and 6 hours followed by normal clinical sign till day 14. Animal no. 9 was observed normal at 30 minutes and 1 hour post dosing, moderate to severe lethargy and mild to moderate ataxia at 2, 3, 4 and 6 hours followed by normal clinical sign till day 14. Animal nos. 10-12 were observed normal at 30 minutes and 1 hour post dosing, mild to moderate lethargy at 2, 3 and 4 hours and mild ataxia at 3 and 4 hours followed by normal clinical sign till day 14. No external and internal gross pathological changes were seen in all the six animals treated with 2000 mg/kg body weight during terminal sacrifice.
Under the conditions of this; acute oral toxicity study of test chemical in female rats is as given below:
The acute oral LD50 value of test chemical was considered to be >2000 mg/kg body weight. Thus by considering the CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not exhibit acute oral toxicity i.e it is acutely non toxic to animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
